First human tests for new Dual-Virus vaccines
NCT ID NCT07516418
Summary
This study aims to test the safety and immune response of new vaccine formulations designed to protect against two viruses: Respiratory Syncytial Virus (RSV) and a specific bird flu strain (H5N1). It will involve 570 healthy participants aged 18 to 49. Researchers will give different versions of the vaccines and closely monitor for side effects and how well the body produces protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.